Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. I: Structuring centers for the multidisciplinary clinical administration and management of CAR-T cell therapy patients

Chimeric antigen receptor T-cells (CAR-T cells) are a new modality of oncological treatment which has demonstrated impressive response in refractory or relapsed diseases, such as acute lymphoblastic leukemia (ALL), lymphomas, and myeloma but is also associated with unique and potentially life-threat...

Descripción completa

Detalles Bibliográficos
Autores principales: Clé, Diego V., Hirayama, Alexandre V., Alencar, Alvaro J., Costa, Luciano J., Feliciano, João V.P., Mattos, Ederson R., Cordeiro, Ana C., Salvino, Marco Aurélio, Barros, George M. Navarro, de Lima, Marcos, Scheinberg, Phillip, Guerino-Cunha, Renato L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2021
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606713/
https://www.ncbi.nlm.nih.gov/pubmed/34794793
http://dx.doi.org/10.1016/j.htct.2021.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606713/
https://www.ncbi.nlm.nih.gov/pubmed/34794793
http://dx.doi.org/10.1016/j.htct.2021.09.001

Ejemplares similares